Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008535 |
---|---|
Receipt number | R000010031 |
Scientific Title | Phase III Study of High-dose Methotrexate and Whole Brain Radiotherapy With or Without Concomitant and Adjuvant Temozolomide in Patients with Primary CNS Lymphoma (JCOG1114C, PCNSL-TMZ-P3) |
Date of disclosure of the study information | 2014/07/30 |
Last modified on | 2021/01/05 16:16:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/07/25 23:07:07 | ||
2 | Update | 2012/07/27 18:37:25 | UMIN ID1 |
|
3 | Update | 2012/09/27 17:08:37 | Date of disclosure of the study information |
|
4 | Update | 2012/11/14 10:41:13 | Anticipated trial start date Last follow-up date |
|
5 | Update | 2012/11/14 10:41:41 | Date of disclosure of the study information |
|
6 | Update | 2013/03/19 20:11:25 | Anticipated trial start date Last follow-up date |
|
7 | Update | 2013/03/19 20:11:48 | Date of disclosure of the study information |
|
8 | Update | 2013/06/13 13:48:03 | Date of disclosure of the study information |
|
9 | Update | 2013/09/13 20:36:38 | Email Date of disclosure of the study information |
|
10 | Update | 2014/02/14 11:27:46 | Date of disclosure of the study information |
|
11 | Update | 2014/04/02 11:11:25 | Date of disclosure of the study information |
|
12 | Update | 2014/05/29 14:35:30 | Date of disclosure of the study information |
|
13 | Update | 2014/07/30 13:58:01 | Public title Public title Acronym Acronym |
|
14 | Update | 2014/07/30 14:00:48 | Condition Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
15 | Update | 2014/07/30 14:10:39 | Randomization unit Stratification Dynamic allocation Institution consideration Blocking Concealment Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
16 | Update | 2014/07/30 14:16:49 | Organization Address Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address Homepage URL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Organization1 Address1 Tel1 Email1 Institutions |
|
17 | Update | 2014/07/30 14:17:55 | Anticipated trial start date Last follow-up date |
|
18 | Update | 2014/09/29 10:12:43 | Recruitment status Anticipated trial start date Last follow-up date |
|
19 | Update | 2014/10/03 14:19:45 | Key inclusion criteria |
|
20 | Update | 2015/11/27 10:41:50 | Other related information Other related information |
|
21 | Update | 2018/01/30 15:16:26 | Name of primary person or sponsor Organization Organization Organization Institutions |
|
22 | Update | 2018/01/30 15:18:18 | Last follow-up date |
|
23 | Update | 2018/02/27 18:18:08 | Institutions |
|
24 | Update | 2018/04/19 15:31:30 | Public title Public title Acronym Acronym |
|
25 | Update | 2018/04/19 15:38:34 | Key inclusion criteria Key inclusion criteria |
|
26 | Update | 2018/04/19 15:44:30 | Organization Organization Division name |
|
27 | Update | 2021/01/05 16:16:16 | Recruitment status Date of IRB |